WIN Symposium 2014

Prof Bernards talks to ecancertv at WIN 2014 about the complexity of intra- and inter-pathway loops in colon cancer and melanoma and the implications for targeted therapies.

Dr Galbraith gives ecancertv the industry perspective on combinations of targeted therapies in oncology at WIN 2014.

Dr Ghosh talks to ecancertv at WIN 2014 about collaborative research across the world, with specific reference to the work that the MD Anderson Cancer Center is doing with sub-Saharan Africa and the cultural differences that need to be negotiated to deliver the best care.

Dr Uhlén talks to ecancertv at WIN 2014 about his work creating the human protein atlas and the development of novel antibodies called affibodies.

Dr Bogler talks to ecancertv at WIN 2014 about how different cancer institutions have collaborated with regards to research on personalised medicine and palliative care.

Dr Hoos talks to ecancertv at WIN 2014 about his investigation of immunological and targeted approaches being combined in particular ways to successfully treat metastatic melanoma with the aim to expand the approach to other cancers.

Prof Mendelsohn, chair of the WIN Consortium, talks to ecancertv at the 2014 symposium about the founding and ongoing work of WIN with particular reference to its role in forwarding personalised medicine and fostering the exchange of ideas and collaboration.

Dr Coukos talks to ecancertv at WIN 2014 about his work looking at immune cells and tumour environment in ovarian cancer.

Dr Pfister talks to ecancertv at WIN 2014 about novel drug targets and potential combinations in treating childhood brain tumours.

Dr Reid talks to ecancertv at WIN 2014 about microRNA replacement as a therapeutic option for malignant pleural mesothelioma. Tests on animals have shown this method to inhibit tumour growth so early stage clinical trials are now in progress.

Prof Clevers talks to ecancertv at WIN 2014 about using single stem cells to grow tissue for cancer research and potentially cancer treatment.

Dr von Kalle talks to ecancertv about haemato-oncology with specific reference to the IDH1 mutation.

Prof Kurzrock talks to ecancertv at WIN 2014 about her work which looks at the genomic complexity of metastatic disease and the difficulty in customising effective combinations to each patient.

Prof Hood talks to ecancertv about the proactive P4 medicine, making blood a window into health and disease that could transform healthcare.

Dr Coukos talks to ecancertv at WIN 2014 about his work looking at immune cells and tumour environment in ovarian cancer.

Dr Raynaud talks to ecancertv at WIN 2014 about the ARC Foundation and the importance of the WIN consortium, with particular reference to the ARC foundation's aim to cure two types of cancer by 2025.